In the News: Goldman Sachs-CSRC Settlement; First Sci-Tech Board Funds Approved; and Drug Administration Law Under Review

Apr 29, 2019
| By Marilyn Romero
The CSRC has agreed its first administrative settlement with Goldman Sachs and Gao Hua Securities; seven themed funds were approved for Shanghai’s new Sci-Tech Board; and the National People's Congress is reviewing measures to tighten up the production and sale of drugs.
SHARE

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
 

Goldman Sachs

This premium content is reserved for
China Law & Practice Subscribers.

Benefits Include:

  • Unlimited access to Chinalawandpractice.com site and digital newsletters
  • 3 free articles* across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

Continue reading by getting
started with a subscription.

Subscribe Now For Unlimited Access